Sheila Sky Kasselman was diagnosed with the most common form of pancreatic cancer in the fall of 2007. She completed chemotherapy, radiation and 'Whipple' surgery to remove her tumor. Nine months after her diagnosis, Sheila founded and dedicated Sky Foundation to finding an early detection for this daunting disease.
Read MoreThe Global SleepHealth Movement and American Sleep Apnea Association Officially Launch the 2016 Sleeptember Campaign with the Introduction of the "GO DARK Sleeptember Pledge" to Raise Critical Funds.
Read MoreNever heard of medication for alcoholism? You're not alone. Eighty-eight thousand Americans will die this year from alcohol dependence. Most will do so without ever knowing of the FDA-approved medications that might have saved their lives.
A controversial new book - 'A Prescription for Alcoholics - Medications for Alcoholism' - takes a first sober look at medication for alcoholics, including the research behind them, and why nobody - including physicians - seems to know about them.
OriGene announced today it has signed an agreement with One World Lab to become a global distributor of OriGene's antibody portfolio that includes premium branded UltraMAB® monoclonal antibodies, internally developed and validated through OriGene's protein high density chips for mono specificity, as well as TrueMAB® monoclonal antibodies that are generated with full length protein antigens.
Read MoreStudy Scavenger and CenterWatch are partnering to provide sponsors, contract research organizations (CROs), research centers and patients a mobile solution to their clinical trial needs.
Read MoreThermodata Corporation Laboratory recently accredited by NVLAP to ISO/IEC 17025. Thermodata Corporation develops and markets temperature monitoring systems for several market sectors; including: health care, food service and academic research.
Read MoreBiliary Cirrhosis - Pipeline Review report provides information on the therapeutic development for Biliary Cirrhosis, complete with latest updates, and special features on late-stage and discontinued projects.
Read MoreEducational Services division of UK based MNC,Helix Research Center has announced Correspondence Certificate Courses in Clinical Research for the Working Professionals as well as Life Sciences Freshers persuing Careers in Clinical Research Worldwide
Read MoreUK based MNC,Helix Research Center has announced Medical Research and GCP Training Services for the Global Biopharmaceutical,Medical Device,Cosmetic companies and other R&D Promoters willing to conduct their Clinical Trials in Russia
Read MoreUK based MNC,Helix Research Center has launched a Campaign to Promote the Concept of 'Alliance of Hospitals' and Establishment of 'Hospital Networks' to Conduct Multinational,Multicentric Clinical Trials in Americas,Afro-Eurasia and Oceania.
Read MoreUK based MNC,Helix Research Center has announced 'GCP Compliance and Clinical Trial Subject Protection Program' for the Researchers and Healthcare Providers in North America,South America,Asia,Africa,Oceania and Europe
Read MoreThe Clinical Research Services Division of UK based MNC,Helix Research Center Ltd has announced,'Professional Services ' for the R&D Stakeholders outsourcing their Clinical Research and Training Projects to CROs Worldwide.
Read MoreEducational Services Division of UK based MNC,Helix Research Center Ltd has announced 'Advanced Web Based,Live Training Program for GCP and GXP Trainers' conducting Training for Clinical Research and Healthcare Industries etc Worldwide
Read MoreUK based MNC,Helix Research Center Ltd has announced Clinical Research and ICH GCP Training Services for the Global Biopharmaceutical,Medical Device and Cosmetic Industry and Global Voluntary Organisations Promoting R&D Services in Japan
Read MoreSpartaMatrix Global Project Engineering Firms expands the scope of its MLC-Croatia Green Energy and Logistics Eastern European Project to now include Indian, Japanese and Korean industry partners.
Read MoreWiley today announced that The Cochrane Collaboration will be renewing its license with India. Indian residents will continue to have complimentary access to reliable, up-to-date, evidence-based health research.
Read More